Healthcare

Radiation Therapy Market Size Analysis 2022 To 2030

The global radiation therapy market size accounted for US$ 6.8 Bn in 2021 and is projected to reach around USD 13.2 Bn by 2030, growing at a CAGR of 7.65% from 2022 to 2030.

Radiation Therapy Market Key Takeaways:

  • North America has accounted revenue share of around 38.7% in 2021.
  • APAC is expected to reach at a CAGR of 7.6% from 2022 to 2030
  • By type, the external beam therapy has captured market share of 81%.
  • By application, the breast cancer segment has contributed highest market share in 2021.
  • By end-users, hospitals segment held highest revenue share 72% in 2021.
Radiation Therapy Market Size 2022 To 2030

 

Report Summary

The global radiation therapy market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the radiation therapy market across the globe.

A comprehensive estimate on the radiation therapy market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of radiation therapy during the forecast period. Price point comparison by region with global average price is also considered in the study.

Radiation Therapy Market Scope

Report CoverageDetails
Market Size in 2022USD 7.32 Billion
Market Size by 2030USD 13.2 Billion
Growth Rate from 2022 to 2030CAGR of 7.65%
Base Year2021
Forecast Period2022 to 2030
Segments CoveredType, Technology, Application, Procedure, End-User, and Geography

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized radiation therapy market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read: Polymers Market Size Analysis 2022 To 2030

Radiation Therapy Market Players

The report includes the profiles of key radiation therapy market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area are Nordion Inc, Siemens healthcare, Mevion medical system, Inc, Isoray, Inc, Icad, Inc, Becton Dickinson and Company, Ion Beam Appications SA, Elekta AB, Eckert & Zeigler Group, Accuray, Incorporated, Varian Medical Syatems, Inc, NTP Radioisotopes SOC Ltd, Curium Pharma, C.R.BARD, Inc, IBA Radiopharma Solutions, ViewRay, Inc, P-cure Ltd, ZEISS Group, Panacea Medical Technologies, Hitachi Ltd

Market Segmentation

By Type

  • Product
  • Service

By Technology

  • External Beam Radiotherapy
    • Linear accelerators
      • Convential linear accelerators
      • Stereotactic advanced Elecron/Cobalt-60-linear accelerators
      • Gamma Knife
      • CyberKnife
      • Tomotherapy
  • Convnetial Cobalt-60 Teletherapy Units
  • Particle Therapy Systems
    • Cyclotrons
    • Synchrotrons
    • Synchrocyclotron
  • Internal Beam Radiotherapy/Brachytherapy
    • Seeds
    • Afterloaders
    • Applicators
    • IORT Systems
  • Systemic Radiotherapy
    • Lobenguane (I-131)
    • Samarium-153
    • Rhenium- 186
    • Others

By Application

  • External Beam Radiotherapy
    • Prostate cancer
    • Breast cancer
    • Lung cancer
    • Head and neck cancer
    • Colorectal cancer
    • Others
  • Internal Beam Radiotherapy/Brachytherapy
    • Prostate cancer
    • Gynecological cancer
    • Breast cancer
    • Cervical cancer
    • Penile cancer
    • Others

By Procedure

  • External Beam Radiotherapy
    • Image guided radiotherapy
    • Intensity-modulated radiotherapy
    • Stereotactic therapy
    • Particle therapy
    • 3D Conformal radiotherapy
  • Internal Beam Radiotherapy/Brachytherapy
    • High-dose-rate Brachytherapy
    • Low-dose-rate Brachytherapy
    • Pulsed-dose-rate Brachytherapy
  • Systemic Radiotherapy
  • Intravenouos Radiotherapy
  • Oral Radiotherapy
  • Instillation Radiotherapy

By End-User

  • Hospitals
  • Independent Radiotherapy Centers

Regional Segmentation

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
  • In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Radiation Therapy Market 

5.1. COVID-19 Landscape: Radiation Therapy Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Radiation Therapy Market, By Type

8.1. Radiation Therapy Market, by Type, 2022-2030

8.1.1. Product

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Service

8.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Radiation Therapy Market, By Technology

9.1. Radiation Therapy Market, by Technology, 2022-2030

9.1.1. External Beam Radiotherapy

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Convnetial Cobalt-60 Teletherapy Units

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Particle Therapy Systems

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Internal Beam Radiotherapy/Brachytherapy

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Systemic Radiotherapy

9.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Radiation Therapy Market, By Application 

10.1. Radiation Therapy Market, by Application, 2022-2030

10.1.1. External Beam Radiotherapy

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Internal Beam Radiotherapy/Brachytherapy

10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Radiation Therapy Market, By Procedure

11.1. Radiation Therapy Market, by Procedure, 2022-2030

11.1.1. External Beam Radiotherapy

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Internal Beam Radiotherapy/Brachytherapy

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Systemic Radiotherapy

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Intravenouos Radiotherapy

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Oral Radiotherapy

11.1.5.1. Market Revenue and Forecast (2017-2030)

11.1.6. Instillation Radiotherapy

11.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Radiation Therapy Market, By End-User

12.1. Radiation Therapy Market, by End-User, 2022-2030

12.1.1. Hospitals

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Independent Radiotherapy Centers

12.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Radiation Therapy Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Type (2017-2030)

13.1.2. Market Revenue and Forecast, by Technology (2017-2030)

13.1.3. Market Revenue and Forecast, by Application (2017-2030)

13.1.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.1.5. Market Revenue and Forecast, by End-User (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Technology (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.1.6.5. Market Revenue and Forecast, by End-User (2017-2030)

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Type (2017-2030)

13.1.7.2. Market Revenue and Forecast, by Technology (2017-2030)

13.1.7.3. Market Revenue and Forecast, by Application (2017-2030)

13.1.7.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.1.7.5. Market Revenue and Forecast, by End-User (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.2. Market Revenue and Forecast, by Technology (2017-2030)

13.2.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.2.5. Market Revenue and Forecast, by End-User (2017-2030)

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Technology (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.7. Market Revenue and Forecast, by Procedure (2017-2030)

13.2.8. Market Revenue and Forecast, by End-User (2017-2030)

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Technology (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.10. Market Revenue and Forecast, by Procedure (2017-2030)

13.2.11. Market Revenue and Forecast, by End-User (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Technology (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.2.13. Market Revenue and Forecast, by End-User (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Technology (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.2.15. Market Revenue and Forecast, by End-User (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.2. Market Revenue and Forecast, by Technology (2017-2030)

13.3.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.3.5. Market Revenue and Forecast, by End-User (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Technology (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.3.7. Market Revenue and Forecast, by End-User (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Technology (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.3.9. Market Revenue and Forecast, by End-User (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Technology (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.3.10.5. Market Revenue and Forecast, by End-User (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Technology (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.3.11.5. Market Revenue and Forecast, by End-User (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.2. Market Revenue and Forecast, by Technology (2017-2030)

13.4.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.4.5. Market Revenue and Forecast, by End-User (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Technology (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.4.7. Market Revenue and Forecast, by End-User (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Technology (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.4.9. Market Revenue and Forecast, by End-User (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Technology (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.4.10.5. Market Revenue and Forecast, by End-User (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Technology (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.4.11.5. Market Revenue and Forecast, by End-User (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Type (2017-2030)

13.5.2. Market Revenue and Forecast, by Technology (2017-2030)

13.5.3. Market Revenue and Forecast, by Application (2017-2030)

13.5.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.5.5. Market Revenue and Forecast, by End-User (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Technology (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.5.7. Market Revenue and Forecast, by End-User (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Type (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Technology (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Application (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.5.8.5. Market Revenue and Forecast, by End-User (2017-2030)

Chapter 14. Company Profiles

14.1. Nordion Inc

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Siemens healthcare

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Mevion medical system, Inc

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Isoray, Inc

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Icad, Inc

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Becton Dickinson and Company

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Ion Beam Appications SA

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Elekta AB

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Eckert & Zeigler Group

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Accuray

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2272

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Show More

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Related Articles

Back to top button